A16S (p.Ala16Ser) variant of SQSTM1 (Sequestosome-1)

A16S (p.Ala16Ser) in SQSTM1 (Sequestosome-1) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in FTDALS3. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data, experimental measurements, and structural context.

A16S (p.Ala16Ser) variant details